Repeated loco-regional therapies for hepatocellular carcinoma is associated with inferior outcome after living donor liver transplantation in cirrhotic patients

被引:3
|
作者
Tsou, Yi-Fan [1 ]
Lin, Niang-Cheng [1 ]
Hsia, Cheng-Yuan [1 ,2 ]
Loong, Che-Chuan [1 ,2 ]
Tsai, Hsin-Lin [1 ,3 ]
Chen, Cheng-Yen [1 ]
Lei, Hao-Jan [1 ,2 ]
Chou, Shu-Cheng [1 ,2 ]
Chung, Meng-Hsuan [1 ]
Kuo, Fang-Cheng [1 ]
Liu, Chin-Su [1 ,3 ]
机构
[1] Taipei Vet Gen Hosp, Dept Surg, Div Transplantat Surg, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Surg, Div Pediat Surg, Taipei, Taiwan
关键词
Hepatocellular carcinoma; Liver transplantation; Living donor liver transplantation; Loco-regional therapy; Outcomes; CHEMOEMBOLIZATION; IMPACT;
D O I
10.1097/JCMA.0000000000000670
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Liver transplantation is the definitive treatment for defined stage hepatocellular carcinoma (HCC) in cirrhotic patients. Loco-regional therapy (LRT) may be considered before transplantation to prevent the disease progression and the patient from dropping out of the waiting list. This study aims to evaluate the impact of repeated pretransplant LRTs on the long-term outcomes in HCC liver transplant recipients. Methods: Between 2004 and 2019, living donor liver transplantation (LDLT) recipients with viable HCC on the explant livers were enrolled. Uni- and multivariate analysis was performed with the Cox regression model to stratify the risk factors associated with HCC recurrence and patent survival after LDLT. Results: A total of 124 patients were enrolled, in which 65.3% (n = 81) were Barcelona Clinic Liver Cancer classification stage B or D and 89% (n = 110) had advanced fibrosis or cirrhosis on the explanted livers. After a median follow-up of 41 months (IQR: 24-86.5), there were 18 cases (13.7%) of HCC recurrence. Univariate analysis showed that the model of end-stage liver disease and Child-Turcotte-Pugh score, pretransplant alpha-fetoprotein value (>500 ng/ml), repeated pretransplant LRTs (N > 4), increased tumor numbers and maximal size, presence of microvascular invasion, and the histological grading of the tumors are risk factors of inferior outcomes. In multivariate analysis, only repeated pretransplant LRTs (N > 4) had a significant impact on both the overall- and recurrence-free survival. The impact of pretransplant LRT was consistently significant among subgroups based on their LRT episodes (N = 0, 1-4, >4 respectively). Conclusion: Repeated LRT for HCC can be associated with the risk of tumor recurrence and inferior patient survival after LDLT in cirrhotic patients. Early referral of those eligible for transplantation may improve the treatment outcomes in these patients.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 50 条
  • [21] Outcomes of single or sequential dual modality loco-regional therapies in Hepatocellular carcinoma
    Balachandrakumar, V. K.
    Swaminathan, M.
    Evans, J.
    Kibriya, N.
    Palmer, D.
    Cross, T.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S206 - S206
  • [22] OUTCOMES OF SINGLE OR SEQUENTIAL DUAL MODALITY LOCO-REGIONAL THERAPIES IN HEPATOCELLULAR CARCINOMA
    Cross, T.
    Swaminathan, M.
    Kibriya, N.
    Evans, J.
    GUT, 2017, 66 : A162 - A163
  • [23] Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
    Akamatsu, Nobuhisa
    Sugawara, Yasuhiko
    Kokudo, Norihiro
    LIVER CANCER, 2014, 3 (02) : 108 - 118
  • [24] Etiological Profiling of Cirrhotic Patients With Hepatocellular Carcinoma Undergoing Living Donor Liver Transplantation in India
    Singh, M.
    Bhangui, P.
    Piplani, T.
    Gautam, D.
    Rastogi, A.
    Goja, S.
    Menon, P. B.
    Sumana, K. R.
    Saraf, N.
    Saigal, S.
    Soin, A. S.
    TRANSPLANTATION, 2015, 99 : 299 - 299
  • [25] Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
    Yonemura, Yusuke
    Yoshizumi, Tomoharu
    Inokuchi, Shoichi
    Kosai-Fujimoto, Yukiko
    Harada, Noboru
    Itoh, Shinji
    Toshima, Takeo
    Takeishi, Kazuki
    Yoshiya, Shohei
    Mori, Masaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2020, 4 (04): : 413 - 421
  • [26] Effect of Tumor Necrosis from Loco-Regional Therapy Prior to Liver Transplantation on Hepatocellular Carcinoma Recurrence after Transplant
    Moonka, Dilip
    Nagai, Shunji
    Gadde, Ramya
    Datta, Lagnajita
    Divine, George
    Abouljoud, Marwan S.
    Salgial, Reena
    HEPATOLOGY, 2016, 64 : 640A - 641A
  • [27] Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation
    Kun-Ming Chan
    Tsung-Han Wu
    Chih-Hsien Cheng
    Chen-Fang Lee
    Ting-Jung Wu
    Hong-Shiue Chou
    Wei-Chen Lee
    Journal of Gastrointestinal Surgery, 2020, 24 : 353 - 360
  • [28] Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation
    Chan, Kun-Ming
    Wu, Tsung-Han
    Cheng, Chih-Hsien
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Lee, Wei-Chen
    JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (02) : 353 - 360
  • [30] A New Strategy for Loco-Regional Therapy of Hepatocellular Carcinoma: Stereotactic Body Radiotherapy as a Bridge to Liver Transplantation
    Uemura, T.
    Kirichenko, A.
    Bunker, M.
    Vincent, M.
    Machado, L.
    Singhal, A.
    Thai, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 434 - 435